D
Treace Medical Concepts, Inc.
TMCI
$7.58
-$0.255-3.26%
D
Sell
3/12/2025Upgraded
Treace Medical Concepts, Inc. (TMCI) was upgraded to D- from E+ on 3/12/2025 due to a noticeable increase in the total return index, volatility index and solvency index. The quick ratio increased from 2.81 to 3.35, and debt to equity declined from 0.51 to 0.48.
Treace Medical Concepts, Inc. (TMCI) was upgraded to D- from E+ on 3/12/2025 due to a noticeable increase in the total return index, volatility index and solvency index. The quick ratio increased from 2.81 to 3.35, and debt to equity declined from 0.51 to 0.48.
E
Sell
11/8/2024Downgrade
Treace Medical Concepts, Inc. (TMCI) was downgraded to E+ from D- on 11/8/2024 due to a decline in the valuation index, solvency index and total return index. Debt to equity increased from 0.48 to 0.51.
Treace Medical Concepts, Inc. (TMCI) was downgraded to E+ from D- on 11/8/2024 due to a decline in the valuation index, solvency index and total return index. Debt to equity increased from 0.48 to 0.51.
D
Sell
10/18/2024Upgraded
Treace Medical Concepts, Inc. (TMCI) was upgraded to D- from E+ on 10/18/2024 due to an increase in the volatility index.
Treace Medical Concepts, Inc. (TMCI) was upgraded to D- from E+ on 10/18/2024 due to an increase in the volatility index.
E
Sell
10/2/2024Downgrade
Treace Medical Concepts, Inc. (TMCI) was downgraded to E+ from D- on 10/2/2024 due to a decline in the volatility index.
Treace Medical Concepts, Inc. (TMCI) was downgraded to E+ from D- on 10/2/2024 due to a decline in the volatility index.
D
Sell
9/13/2024Upgraded
Treace Medical Concepts, Inc. (TMCI) was upgraded to D- from E+ on 9/13/2024 due to an increase in the volatility index and valuation index.
Treace Medical Concepts, Inc. (TMCI) was upgraded to D- from E+ on 9/13/2024 due to an increase in the volatility index and valuation index.
E
Sell
7/8/2024Downgrade
Treace Medical Concepts, Inc. (TMCI) was downgraded to E+ from D- on 7/8/2024 due to a decline in the volatility index, total return index and valuation index.
Treace Medical Concepts, Inc. (TMCI) was downgraded to E+ from D- on 7/8/2024 due to a decline in the volatility index, total return index and valuation index.
D
Sell
6/18/2024Upgraded
Treace Medical Concepts, Inc. (TMCI) was upgraded to D- from E+ on 6/18/2024 due to an increase in the volatility index.
Treace Medical Concepts, Inc. (TMCI) was upgraded to D- from E+ on 6/18/2024 due to an increase in the volatility index.
E
Sell
6/3/2024Downgrade
Treace Medical Concepts, Inc. (TMCI) was downgraded to E+ from D- on 6/3/2024 due to a decline in the total return index and volatility index.
Treace Medical Concepts, Inc. (TMCI) was downgraded to E+ from D- on 6/3/2024 due to a decline in the total return index and volatility index.
D
Sell
5/17/2024Upgraded
Treace Medical Concepts, Inc. (TMCI) was upgraded to D- from E+ on 5/17/2024 due to an increase in the valuation index.
Treace Medical Concepts, Inc. (TMCI) was upgraded to D- from E+ on 5/17/2024 due to an increase in the valuation index.
E
Sell
7/21/2023Downgrade
Treace Medical Concepts, Inc. (TMCI) was downgraded to E+ from D- on 7/21/2023 due to a decline in the volatility index.
Treace Medical Concepts, Inc. (TMCI) was downgraded to E+ from D- on 7/21/2023 due to a decline in the volatility index.
D
Sell
7/6/2023Upgraded
Treace Medical Concepts, Inc. (TMCI) was upgraded to D- from E+ on 7/6/2023 due to an increase in the volatility index and valuation index.
Treace Medical Concepts, Inc. (TMCI) was upgraded to D- from E+ on 7/6/2023 due to an increase in the volatility index and valuation index.
E
Sell
6/16/2023Downgrade
Treace Medical Concepts, Inc. (TMCI) was downgraded to E+ from D- on 6/16/2023 due to a decline in the volatility index.
Treace Medical Concepts, Inc. (TMCI) was downgraded to E+ from D- on 6/16/2023 due to a decline in the volatility index.
D
Sell
5/18/2023Upgraded
Treace Medical Concepts, Inc. (TMCI) was upgraded to D- from E+ on 5/18/2023 due to an increase in the solvency index, volatility index and valuation index. The quick ratio increased from 3.65 to 8.41, and debt to equity declined from 0.88 to 0.34.
Treace Medical Concepts, Inc. (TMCI) was upgraded to D- from E+ on 5/18/2023 due to an increase in the solvency index, volatility index and valuation index. The quick ratio increased from 3.65 to 8.41, and debt to equity declined from 0.88 to 0.34.
E
Sell
5/11/2023Downgrade
Treace Medical Concepts, Inc. (TMCI) was downgraded to E+ from D- on 5/11/2023 due to a decline in the volatility index, valuation index and growth index.
Treace Medical Concepts, Inc. (TMCI) was downgraded to E+ from D- on 5/11/2023 due to a decline in the volatility index, valuation index and growth index.
D
Sell
3/14/2023Downgrade
Treace Medical Concepts, Inc. (TMCI) was downgraded to D- from D on 3/14/2023 due to a decline in the solvency index and valuation index. The quick ratio declined from 4.74 to 3.65, and debt to equity increased from 0.85 to 0.88.
Treace Medical Concepts, Inc. (TMCI) was downgraded to D- from D on 3/14/2023 due to a decline in the solvency index and valuation index. The quick ratio declined from 4.74 to 3.65, and debt to equity increased from 0.85 to 0.88.
D
Sell
2/23/2023Upgraded
Treace Medical Concepts, Inc. (TMCI) was upgraded to D from D- on 2/23/2023 due to an increase in the valuation index.
Treace Medical Concepts, Inc. (TMCI) was upgraded to D from D- on 2/23/2023 due to an increase in the valuation index.
D
Sell
2/8/2023Downgrade
Treace Medical Concepts, Inc. (TMCI) was downgraded to D- from D on 2/8/2023 due to a decline in the solvency index and valuation index. The quick ratio declined from 7.09 to 4.74, and debt to equity increased from 0.74 to 0.85.
Treace Medical Concepts, Inc. (TMCI) was downgraded to D- from D on 2/8/2023 due to a decline in the solvency index and valuation index. The quick ratio declined from 7.09 to 4.74, and debt to equity increased from 0.74 to 0.85.
D
Sell
9/14/2022Upgraded
Treace Medical Concepts, Inc. (TMCI) was upgraded to D from D- on 9/14/2022 due to an increase in the total return index, volatility index and growth index. Total revenue increased 3.17% from $29.05M to $29.97M.
Treace Medical Concepts, Inc. (TMCI) was upgraded to D from D- on 9/14/2022 due to an increase in the total return index, volatility index and growth index. Total revenue increased 3.17% from $29.05M to $29.97M.
D
Sell
5/31/2022Upgraded
Treace Medical Concepts, Inc. (TMCI) was upgraded to D- from E+ on 5/31/2022 due to an increase in the volatility index.
Treace Medical Concepts, Inc. (TMCI) was upgraded to D- from E+ on 5/31/2022 due to an increase in the volatility index.
E
Sell
5/13/2022Downgrade
Treace Medical Concepts, Inc. (TMCI) was downgraded to E+ from D- on 5/13/2022 due to a decline in the growth index, total return index and solvency index. Operating cash flow declined 92.99% from -$3.75M to -$7.24M, EBIT declined 44.65% from -$5.6M to -$8.1M, and earnings per share declined from -$0.1234 to -$0.1648.
Treace Medical Concepts, Inc. (TMCI) was downgraded to E+ from D- on 5/13/2022 due to a decline in the growth index, total return index and solvency index. Operating cash flow declined 92.99% from -$3.75M to -$7.24M, EBIT declined 44.65% from -$5.6M to -$8.1M, and earnings per share declined from -$0.1234 to -$0.1648.
D
Sell
5/5/2022Upgraded
Treace Medical Concepts, Inc. (TMCI) was upgraded to D- from E+ on 5/5/2022 due to an increase in the total return index.
Treace Medical Concepts, Inc. (TMCI) was upgraded to D- from E+ on 5/5/2022 due to an increase in the total return index.
E
Sell
4/20/2022Downgrade
Treace Medical Concepts, Inc. (TMCI) was downgraded to E+ from D- on 04/20/2022.
Treace Medical Concepts, Inc. (TMCI) was downgraded to E+ from D- on 04/20/2022.
D
Sell
3/4/2022Downgrade
Treace Medical Concepts, Inc. (TMCI) was downgraded to D- from D on 3/4/2022 due to a substantial decline in the efficiency index, total return index and volatility index. Total capital declined 3.35% from $126.87M to $122.61M, and net income declined 3.13% from -$6.42M to -$6.62M.
Treace Medical Concepts, Inc. (TMCI) was downgraded to D- from D on 3/4/2022 due to a substantial decline in the efficiency index, total return index and volatility index. Total capital declined 3.35% from $126.87M to $122.61M, and net income declined 3.13% from -$6.42M to -$6.62M.
D
Sell
8/6/2021None
Treace Medical Concepts, Inc. (TMCI) was downgraded to D from U on 08/06/2021.
Treace Medical Concepts, Inc. (TMCI) was downgraded to D from U on 08/06/2021.
NASDAQ
04/04/2025 12:48PM Eastern
Quotes delayed
